Kamu erişimi zorunlu olan makaleler - Xando Díaz-VillamarínDaha fazla bilgi edinin
Bir yerde sunuluyor: 6
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
JJ Swen, CH van der Wouden, LEN Manson, H Abdullah-Koolmees, ...
The Lancet 401 (10374), 347-356, 2023
Zorunlu olanlar: UK Medical Research Council, National Institute for Health Research, UK …
Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent
J Sánchez-Ramos, CL Dávila-Fajardo, PT Frías, XD Villamarín, ...
International journal of cardiology 225, 289-295, 2016
Zorunlu olanlar: Government of Spain
Pharmacogenomics decision support in the U-PGx project: results and advice from clinical implementation across seven European countries
K Blagec, JJ Swen, R Koopmann, KC Cheung, ...
PloS one 17 (6), e0268534, 2022
Zorunlu olanlar: National Institute of Health and Medical Research, France, National …
A new pharmacogenetic algorithm to predict the most appropriate dosage of acenocoumarol for stable anticoagulation in a mixed Spanish population
HY Tong, CL Dávila-Fajardo, AM Borobia, LJ Martínez-González, ...
PloS one 11 (3), e0150456, 2016
Zorunlu olanlar: Government of Spain
Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study
MI Koufaki, V Fragoulakis, X Díaz-Villamarín, K Karamperis, A Vozikis, ...
Human Genomics 17 (1), 51, 2023
Zorunlu olanlar: European Commission, Government of Spain
The study protocol for a non-randomized controlled clinical trial using a genotype-guided strategy in a dataset of patients who undergone percutaneous coronary intervention …
CL Dávila-Fajardo, J Sánchez-Ramos, X Diaz-Villamarín, ...
Data in brief 10, 518-524, 2017
Zorunlu olanlar: Government of Spain
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir